[HTML][HTML] Integrating loco-regional hyperthermia into the current oncology practice: SWOT and TOWS analyses

NR Datta, HP Kok, H Crezee, US Gaipl… - Frontiers in oncology, 2020 - frontiersin.org
Moderate hyperthermia at temperatures between 40 and 44° C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.

NR Datta, HP Kok, H Crezee, US Gaipl, S Bodis - Frontiers in oncology, 2020 - sonar.ch
English Moderate hyperthermia at temperatures between 40 and 44 C is a multifaceted
therapeutic modality. It is a potent radiosensitizer, interacts favorably with a host of …

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses

NR Datta, HP Kok, H Crezee, US Gaipl, S Bodis - open.fau.de
Moderate hyperthermia at temperatures between 40 and 44 C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.

NR Datta, HP Kok, H Crezee, US Gaipl… - Frontiers in …, 2020 - europepmc.org
Moderate hyperthermia at temperatures between 40 and 44 C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.

NR Datta, HP Kok, H Crezee, US Gaipl, S Bodis - Frontiers in oncology, 2020 - folia.unifr.ch
English Moderate hyperthermia at temperatures between 40 and 44 C is a multifaceted
therapeutic modality. It is a potent radiosensitizer, interacts favorably with a host of …

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses

NR Datta, HP Kok, H Crezee… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Moderate hyperthermia at temperatures between 40 and 44° C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses

NR Datta, HP Kok, H Crezee… - Frontiers in …, 2020 - researchinformation.amsterdamumc …
Moderate hyperthermia at temperatures between 40 and 44 C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses

NR Datta, HP Kok, H Crezee, US Gaipl… - Frontiers in …, 2020 - opus4.kobv.de
Moderate hyperthermia at temperatures between 40 and 44° C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

[PDF][PDF] Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses

NR Datta, HP Kok, H Crezee, US Gaipl, S Bodis - eclass.upatras.gr
Datta et al. Hyperthermia: SWOT and TOWS Analyses categorizes future strategies to
facilitate further integration of hyperthermia with the current treatment modalities. These …

[PDF][PDF] Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses

NR Datta, HP Kok, H Crezee, US Gaipl, S Bodis - researchgate.net
Datta et al. Hyperthermia: SWOT and TOWS Analyses categorizes future strategies to
facilitate further integration of hyperthermia with the current treatment modalities. These …